Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 87,237 | 7,386 | 5,825 | 3,714 | 0 |
| Operating Income | -87,237 | -7,386 | -5,825 | -3,714 | N/A |
| Other Income | -6,816 | -75,804 | -11,132 | 19,594 | 0 |
| Pre-tax Income | -94,053 | -83,190 | -16,957 | 15,880 | 0 |
| Income Tax | 309 | -4 | N/A | N/A | N/A |
| Net Income Continuous | -94,362 | -83,186 | -16,957 | 15,880 | N/A |
| Minority Interests | -7,761 | 1 | -600 | -422 | N/A |
| Net Income | $-86,593 | $-83,195 | $-16,357 | $16,302 | $N/A |
| EPS Basic Total Ops | -0.91 | -0.92 | -0.18 | 0.18 | N/A |
| EPS Basic Continuous Ops | -0.99 | -0.92 | -0.19 | 0.18 | N/A |
| EPS Diluted Total Ops | -0.89 | -0.92 | -0.18 | 0.16 | N/A |
| EPS Diluted Continuous Ops | -0.99 | -0.92 | -0.19 | 0.17 | N/A |
| EBITDA(a) | $-87,223 | $-7,381 | $-5,822 | $-3,712 | $N/A |